Plain-English translation of NCT06790082 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a new type of medical scan called FAPI PET that may be better at detecting pleural mesothelioma — a serious cancer that forms in the thin layer of tissue covering the lungs. The scan works differently than standard scans and early research suggests it may catch the cancer more accurately and help doctors stage it better, which could change how patients are treated.
Most patients with pleural mesothelioma are diagnosed at advanced stages when surgery is not an option, and treatment decisions depend heavily on accurate staging. This medication has shown promise in early studies of mesothelioma patients, detecting the cancer better than conventional scans and even changing the treatment plan for some patients, but more evidence is needed to confirm its value.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will undergo an additional specialized scan called FAPI PET/CT as part of your initial staging workup for mesothelioma. If you are a woman of childbearing age, you will have a pregnancy test within 48 hours before the scan. The scan itself involves lying still in an imaging machine for several minutes while a small amount of radioactive tracer circulates through your body — it works similarly to standard PET scans you may have already had, but uses a different tracer that may show the cancer more clearly.
AI-generated summary from trial data · Aug 8, 2026 · Not medical advice
Denmark